Page last updated: 2024-08-25

methotrexate and Carcinoma, Ductal, Pancreatic

methotrexate has been researched along with Carcinoma, Ductal, Pancreatic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abolhassani, M; Baronzio, G; Behzadi, M; Campion, F; Fiorentini, G; Guais, A; Mainini, C; Montagnani, F; Sanders, E; Schwartz, L1

Other Studies

1 other study(ies) available for methotrexate and Carcinoma, Ductal, Pancreatic

ArticleYear
Adding a combination of hydroxycitrate and lipoic acid (METABLOCâ„¢) to chemotherapy improves effectiveness against tumor development: experimental results and case report.
    Investigational new drugs, 2012, Volume: 30, Issue:1

    Topics: Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cisplatin; Citrates; Deoxycytidine; Energy Metabolism; Female; Gemcitabine; Humans; Methotrexate; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Pancreatic Neoplasms; Thioctic Acid; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder Neoplasms

2012